close

Agreements

Date: 2015-05-06

Type of information: Construction of new premises

Compound: Lilly Cambridge Innovation Center

Company: Eli Lilly (USA - IN)

Therapeutic area:

Type agreement:

construction of new premises

Action mechanism:

Disease:

Details:

* On May 6, 2015, Eli Lilly announced plans to establish a new drug delivery and device innovation center in Cambridge, Massachusetts - a strategic location that will help attract top scientists and bioengineers, as well as enhance Lilly\'s local business development presence. The Lilly Cambridge Innovation Center, a makerspace located in Kendall Square, will allow leading life science experts and organizations to explore how emerging technologies and connectivity can advance drug delivery and device innovation to improve patient health. The center will serve as a portal for external partnerships and collaboration activities with the company\'s existing research facilities in San Diego, New York City and Indianapolis.

Construction of the Lilly Cambridge Innovation Center will begin immediately, with an expected occupancy by the end of 2015. Over the next two years, the company will hire about 30 scientists and engineers to fulfill the center\'s work. When fully operational, the center will increase the company\'s delivery and device research and development space by nearly 50 percent, while increasing its staff by 25 percent.

Financial terms:

Latest news:

Is general: Yes